Clinical Trial: A Clinical Study of RSS0343 in Healthy Subjects

U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289464) titled 'A Clinical Study of RSS0343 in Healthy Subjects' on Dec. 04.

Brief Summary: This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of RSS0343 following multiple oral doses in healthy subjects, as well as its effects on the QT/QTc interval.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Non-cystic Fibrosis Bronchiectasis

Intervention: DRUG: RSS0343 Tablets

RSS0343 tablets, oral.

DRUG: RSS0343 Tablets Placebo

RSS0343 tablets placebo, oral.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Reistone Biopharma Company Limited

Disclaimer: Curated by HT Syndication....